临床药物治疗杂志2024,Vol.22Issue(2) :1-5,13.DOI:10.3969/j.issn.1672-3384.2024.02.001

布立西坦治疗癫痫的研究进展

Research progress of brivaracetam in the treatment of epilepsy

刘成裕 刘代华 李俊明 曾坤 覃禹
临床药物治疗杂志2024,Vol.22Issue(2) :1-5,13.DOI:10.3969/j.issn.1672-3384.2024.02.001

布立西坦治疗癫痫的研究进展

Research progress of brivaracetam in the treatment of epilepsy

刘成裕 1刘代华 1李俊明 1曾坤 1覃禹1
扫码查看

作者信息

  • 1. 广西医科大学附属柳州市人民医院 药学部,广西 柳州 545006
  • 折叠

摘要

药物治疗是癫痫的主要治疗手段,然而传统抗癫痫药物不良反应明显,患者耐受性较差,限制了其在临床中的应用.布立西坦作为第3代新型抗癫痫药物,主要用于局灶性癫痫的添加治疗和单药治疗,也是治疗全面性癫痫和癫痫持续状态的潜在选择.与传统抗癫痫药物相比,布立西坦具有更高的安全性和耐受性.本文综述了布立西坦的作用机制、药动学特征、疗效和安全性,以期为癫痫治疗提供更有效的选择.

Abstract

Pharmacotherapy is the mainstay treatment of epilepsy;however,the significant adverse reactions and poor tolerance associated with traditional antiepileptic drugs limit their clinical application.Brivaracetam,as the third-generation new antiepileptic drug,is mainly indicated for adjunctive therapy and monotherapy for patients with focal epilepsy,and pres-ents a potential option for the treatment of generalized epilepsy and status epilepticus.Compared to the traditional antiepileptic drugs,brivaracetam offers higher safety and tolerability.This article reviews the mechanism of action,pharmacokinetic charac-teristics,efficacy and safety of brivaracetam,aiming to provide more effective choices for the treatment of epilepsy.

关键词

布立西坦/癫痫/添加治疗/单药治疗/疗效/安全性

Key words

brivaracetam/epilepsy/adjunctive therapy/monotherapy/efficacy/safety

引用本文复制引用

基金项目

广西药学会医院药学科研项目(GXYXH1-202210)

出版年

2024
临床药物治疗杂志
北京药学会

临床药物治疗杂志

CSTPCD
影响因子:1.07
ISSN:1672-3384
参考文献量42
段落导航相关论文